Publications
Found 9 results
Filters: Author is Xavier, Catarina [Clear All Filters]
"Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.",
Contrast Media Mol Imaging, vol. 11, issue 5, pp. 328-339, 2016 09.
"Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.",
Expert Opin Drug Deliv, vol. 11, issue 12, pp. 1939-54, 2014 Dec.
"Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.",
Bioconjug Chem, vol. 25, issue 5, pp. 979-88, 2014 May 21.
"Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.",
Mol Imaging Biol, vol. 16, issue 5, pp. 690-8, 2014 Oct.
"Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.",
Theranostics, vol. 4, issue 7, pp. 708-20, 2014.
"Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.",
J Nucl Med, vol. 54, issue 5, pp. 776-84, 2013 May.
"Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.",
Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
"Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.",
Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
"Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.",
FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.